Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Exit

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Google points North to acquisition
Google paid a reported $180m for Amazon and Intel-backed North Wearables, the augmented reality glasses developer having sought a buyer since spring.
QuantumCTek cultivates $102m IPO
Legend Capital-backed quantum computing technology developer QuantumCTek has filed to raise up to $102m in an initial public offering in Shanghai.
Shift gears up for reverse merger
The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.
Mirror reflects on $500m acquisition
At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.
SGX sets aside $128m to buy BidFX
Trading bourse owner SGX will take over the remaining 80% of the FX trading platform operator, its Asian Gateway Investments vehicle having invested $25m last year.
Empower to purchase Personal Capital for $825m
BBVA, USAA and Power Financial are set to exit wealth management technology provider Personal Capital in an $825m transaction.
Genor Biopharma generates filing for $320m IPO
The autoimmune disease and cancer drug developer plans to float in Hong Kong having recently secured $160m from investors including a Charoen Pokphand-backed fund.

Other News

Berkeley Lights works towards $100m IPO
The cell biology technology provider, which counts Nikon and Varian Medical among its investors, has raised about $215m in venture funding.
Pandion plans $75m initial public offering
SR One and Roche Venture Fund-backed Pandion Therapeutics will use the proceeds from the offering to advance a lead drug candidate for ulcerative colitis.
Akouos acquires $213m in initial public offering
The hearing loss treatment developer, which counts Novartis Venture Fund and Partners Innovation Fund as investors, floated above its range.
Fusion Pharma fetches $213m in IPO
Johnson & Johnson and Varian Medical exited the cancer radiotherapy developer in an upsized initial public offering after $158m in funding.
Analysis: Mastercard buys Finicity for $825m
Mastercard will buy financial data technology provider Finicity in a deal that could reach $985m, giving Experian an exit. This is yet another large exits in this space this year after the acquisitions of Plaid and Credit Karma earlier.
Agora accomplishes $350m flotation
The SIG-backed video communication software provider priced its shares above the range and will go public later today.

Editor's Picks

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Forma Therapeutics finishes IPO at $319m
Forma Therapeutics, whose investors include Eli Lilly and Novartis, has closed its IPO after seeing its shares double in price.
Forma forces its way to $278m IPO
The Novartis and Eli Lilly-backed cancer and haematologic disease drug developer will go public today having expanded the size of its offering.
Avidity achieves $259m initial public offering
Muscle disease drug developer Avidity, which counts Eli Lilly, EMS, Takeda and ST Pharm as investors, went public in a significantly upized IPO.
test reg

Login